If there’s one company that believes in the digital health revolution, it’s LEO Pharma. According to news sources and a press release from the Denmark-based company, last year LEO Pharma invested $3.4M in SkinVision, the developer of a mobile app that helps detect melanoma, a serious form of skin cancer. Simply snap a picture of a spot on your skin, wait a second for the app to analyze it, and you’ll get an instant reading and recommendation. You can also track spots over time to see if they change.
According to Kim Kjoeller, Senior Vice President of Global Development at LEO Pharma, “The Internet is dramatically changing how consumers manage their health and this creates new opportunities for us to deliver innovative, value-added services and LEO Pharma wants to be at the forefront of that trend.”
This is a smart play for the pharma company, considering their deep focus on the development of drugs and other therapies to treat a variety of skin conditions. In addition to the access of “digital learnings,” such an app could help LEO Pharma educate and market treatments to patients.
